149 related articles for article (PubMed ID: 10666082)
1. Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats.
Liu YH; Yang XP; Mehta D; Bulagannawar M; Scicli GM; Carretero OA
Am J Physiol Heart Circ Physiol; 2000 Feb; 278(2):H507-14. PubMed ID: 10666082
[TBL] [Abstract][Full Text] [Related]
2. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
[TBL] [Abstract][Full Text] [Related]
3. Role of angiotensin II type 2 receptors and kinins in the cardioprotective effect of angiotensin II type 1 receptor antagonists in rats with heart failure.
Liu YH; Yang XP; Shesely EG; Sankey SS; Carretero OA
J Am Coll Cardiol; 2004 Apr; 43(8):1473-80. PubMed ID: 15093886
[TBL] [Abstract][Full Text] [Related]
4. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice.
Yang XP; Liu YH; Mehta D; Cavasin MA; Shesely E; Xu J; Liu F; Carretero OA
Circ Res; 2001 May; 88(10):1072-9. PubMed ID: 11375278
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model.
Koch M; Bonaventura K; Spillmann F; Dendorfer A; Schultheiss HP; Tschöpe C
Biol Chem; 2008 Jun; 389(6):719-23. PubMed ID: 18627293
[TBL] [Abstract][Full Text] [Related]
6. Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats.
Yang XP; Liu YH; Scicli GM; Webb CR; Carretero OA
Hypertension; 1997 Sep; 30(3 Pt 2):735-40. PubMed ID: 9323015
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H
Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180
[TBL] [Abstract][Full Text] [Related]
8. Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure.
Cavasin MA; Yang XP; Liu YH; Mehta D; Karumanchi R; Bulagannawar M; Carretero OA
J Cardiovasc Pharmacol; 2000 Oct; 36(4):472-80. PubMed ID: 11026648
[TBL] [Abstract][Full Text] [Related]
9. Effect of Chronic Blockade of the Kallikrein-Kinin System on the Development of Hypertension in Rats.
Rhaleb NE; Yang XP; Nanba M; Shesely EG; Carretero OA
Hypertension; 2001 Jan; 37(1):121-128. PubMed ID: 11208766
[TBL] [Abstract][Full Text] [Related]
10. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure.
Liu YH; Xu J; Yang XP; Yang F; Shesely E; Carretero OA
Hypertension; 2002 Feb; 39(2 Pt 2):375-81. PubMed ID: 11882576
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats.
Ito H; Hayashi I; Izumi T; Majima M
Br J Pharmacol; 2003 Jan; 138(1):225-33. PubMed ID: 12522094
[TBL] [Abstract][Full Text] [Related]
12. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
Nolly H; Miatello R; Damiani MT; Abate CD
Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545
[TBL] [Abstract][Full Text] [Related]
13. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
14. Effects of a neutral endopeptidase inhibitor, BP102, on the development of deoxycorticosterone acetate-salt hypertension in kininogen-deficient Brown Norway Katholiek rats.
Nakajima S; Majima M; Ito H; Hayashi I; Yajima Y; Katori M
Int J Tissue React; 1998; 20(2):45-56. PubMed ID: 9638501
[TBL] [Abstract][Full Text] [Related]
15. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
Linz W; Wiemer G; Schölkens BA
Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
[TBL] [Abstract][Full Text] [Related]
16. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
[TBL] [Abstract][Full Text] [Related]
17. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.
Wolfrum S; Richardt G; Dominiak P; Katus HA; Dendorfer A
Br J Pharmacol; 2001 Sep; 134(2):370-4. PubMed ID: 11564655
[TBL] [Abstract][Full Text] [Related]
18. The kinin B1 receptor contributes to the cardioprotective effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in mice.
Xu J; Carretero OA; Shesely EG; Rhaleb NE; Yang JJ; Bader M; Yang XP
Exp Physiol; 2009 Mar; 94(3):322-9. PubMed ID: 19060116
[TBL] [Abstract][Full Text] [Related]
19. Kinins are implicated of the hypotensive effect of acidic fibroblast growth factor.
Saenz de Tejada I; Carceller F; Fernandez A; Cuevas B; Ortes L; Giménez-Gallego G; Cuevas P
Eur J Med Res; 1997 Jul; 2(7):302-4. PubMed ID: 9233905
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II.
Stauss HM; Zhu YC; Redlich T; Adamiak D; Mott A; Kregel KC; Unger T
J Cardiovasc Risk; 1994 Oct; 1(3):255-62. PubMed ID: 7621306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
